COVID-19 Resource Center
As the pandemic continues to impact our daily lives, the Quadax Resource Center is here to help keep you up to date on the latest COVID-19 topics, including payor and billing changes affecting reimbursement.
Recent Blog Posts
Preparing Your Revenue Cycle for the End of the PHE
As the expiration of the PHE draws near, healthcare providers face a litany of uncertainty. By being proactive and understanding the changes and implications to reimbursement, providers can minimize the potential negative impact on their patients and their own bottom line.
COVID-19 Articles, Bulletins, Town Halls, Webinars
Date | Article | Source |
5/5/2023 | WHO declares end to Covid global health emergency | |
5/4/2023 | COVID-19: Reporting CR Modifier & DR Condition Code After Public Health Emergency Update | |
5/1/2023 | CMS Announces Upcoming Changes to COVID-19 Test Reimbursement Policies | |
2/27/2023 | COVID-19 Public Health Emergency (PHE) New Overview Fact Sheet | |
2/23/2023 | Provider-specific fact sheets about COVID-19 Public Health Emergency (PHE) waivers and flexibilities | |
2/9/2023 | How Will the End of the PHE Affect Telehealth and Digital Health? | |
2/9/2023 | Fact Sheet: COVID-19 Public Health Emergency Transition Roadmap | |
2/9/2023 | Letter to U.S. Governors from HHS Secretary Xavier Becerra on renewing COVID-19 Public Health Emergency (PHE) | |
1/30/2023 | President Biden to end Covid-19 emergencies on May 11 | |
12/8/2022 | Rev Cycle Leaders Are Still Eyeing COVID-19 Reporting | |
11/11/2022 | U.S. COVID public health emergency to stay in place | |
11/2/2022 | FDA Revises EUAs for COVID-19 Antigen Tests | |
10/13/2022 | HHS renews COVID-19 public health emergency for 90 days | |
10/5/2022 | COVID-19 Testing Lab Can’t Sue Insurer for Violating CARES Act Obligations | |
9/27/2022 | FDA Updates COVID-19 Test Policy, Encourages Developers to Seek Traditional Premarket Review for Most Test Types | |
9/26/2022 | CMS Rescinds December 7, 2020, Enforcement Discretion for the Use of SARS-CoV-2 Tests on Asymptomatic Individuals Outside of the Test’s Instructions for Use | |
9/13/2022 | FDA Roundup | |
9/12/2022 | Updated COVID-19 Vaccines Providing Protection Against Omicron Variant Available at No Cost | |
9/7/2022 | AMA Update: Fall boosters, new CPT codes, and more | |
9/7/2022 | Commercializing COVID likely means more out-of-pocket costs | |
8/31/2022 | Rebounds in Core Lab Services Offset Declines in COVID-19 Test Revenues | |
8/31/2022 | FDA Authorizes Moderna, Pfizer-BioNTech Bivalent COVID-19 Vaccines for Use as a Booster Dose | |
8/19/2022 | FDA's Work to Combat the COVID-19 Pandemic | |
8/18/2022 | Laboratories: CMS Flexibilities to Fight COVID-19 | |
8/18/2022 | Creating a Roadmap for the End of the COVID-19 Public Health Emergency | |
8/16/2022 | COVID-19 Frequently Asked Questions (FAQs) on | |
8/12/2022 | FDA Advises Repeat Testing to Reduce False Negative Results with COVID-19 Antigen Tests | |
8/2/2022 | Lab Update: Clinical Laboratory COVID-19 Response Calls Are Now LOCS Calls | |
7/29/2022 | Biden-Harris Administration Secures 66 Million Doses of Moderna’s Variant-Specific COVID-19 Vaccine Booster for Potential Use in Fall and Winter 2022 | |
6/8/2022 | COVID-19 test demand a boon for labs, a bane for costs, study finds | |
6/7/2022 | New Current Procedural Terminology (CPT®) codes have been created that streamline the reporting of immunizations for the novel coronavirus (SARS-CoV-2, also known as COVID-19). | |
6/7/2022 | FDA Roundup: Additional guidance to help prescribers evaluate potential drug interactions when using Paxlovid therapy for COVID-19 | |
6/3/2022 | HHS Extends American Rescue Plan Spending Deadline for States to Expand and Enhance Home- and Community-Based Services for People with Medicaid | |
5/26/2022 | New Administration Code for Pfizer Pediatric Vaccine Booster Dose. | |
5/25/2022 | Provider Relief Fund Reporting Requirements and Auditing | |
5/25/2022 | What Happens to COVID Tests After Public Health Emergency Ends? | |
5/20/2022 | Know Your Treatment Options for COVID-19 Consumer Update - Refreshed | |
5/17/2022 | The FDA issued an Emergency Use Authorization (EUA) for the Laboratory Corporation of America (Labcorp) Pixel by Labcorp COVID-19+Flu+RSV Test Home Collection Kit for use with the Labcorp Seasonal Respiratory Virus RT-PCR DTC Test | |
5/17/2022 | Federal government offers more free COVID-19 tests | |
5/16/2022 | HHS to Discontinue Providing Viral Transport Media to States and Jurisdictions | |
5/16/2022 | Hospital Groups Ask HHS to Expand COVID-19 Public Health Emergency | |
5/10/2022 | U.S. will limit next-generation Covid vaccines to high-risk people this fall if Congress doesn’t approve more funding | |
5/6/2022 | Rising hospitalizations put CDC's COVID-19 prevention guidelines to the test | |
5/5/2022 | Federal funds for uninsured COVID patients dry up as hospital costs rise | |
5/5/2022 | Labor, Medications, and Supply Costs Plague Hospitals and Health Systems | |
5/4/2022 | How One Medicaid Program May Prevent Coverage Loss Post-COVID | |
5/5/2022 | FDA Limits Use of Janssen COVID-19 Vaccine to Certain Individuals | |
5/2/2022 | Loss of Pandemic Aid Stresses Hospitals That Treat The Uninsured | |
4/27/2022 | COVID-19 Uninsured Relief Fund Joint Letter | |
4/26/2022 | FACT SHEET: Biden Administration Increases Access to COVID-19 Treatments and Boosts Patient and Provider Awareness | |
4/26/2022 | CDC estimates 58% of Americans have been infected with SARS-CoV-2 | |
4/26/2022 | White House expands access to COVID-19 antiviral pills | |
4/19/2022 | HHS Distributes $1.75B in Phase 4 COVID-19 Provider Relief Funds | |
4/14/2022 | COVID-19: New Codes for Moderna Vaccine Booster Doses | |
4/12/2022 | Renewal of Determination That A Public Health Emergency Exists | |
4/7/2022 | System Limitation Update for Centralized Flu Billers (CFB), Pneumococcal and Covid-19 Vaccinations | |
4/6/2022 | The Uninsured Program stopped accepting claims due to a lack of sufficient funds | |
4/6/2022 | Eligible Individuals Can Receive Second COVID-19 Booster Shot at No Cost | |
4/4/2022 | Telehealth Place of Service Code | |
4/4/2022 | Biden-Harris Administration Announces New Way for Medicare Beneficiaries to Get Free Over-the-Counter COVID-19 Tests | |
4/1/2022 | FDA Roundup - Revised guidance: Emergency Use Authorization for Vaccines to Prevent COVID-19 | |
3/31/2022 | Medicare Fee-for-Service Claims and the Sequestration Payment Adjustment Changes | |
3/31/2022 | COVID-19 guidance for your community | |
3/31/2022 | COVID pandemic’s end may bring turbulence for US health care | |
3/29/2022 | FDA Roundup: Manufacturing change for Moderna COVID-19 Vaccine | |
3/29/2022 | FDA Authorizes Second Booster Dose of Two COVID-19 Vaccines for Older and Immunocompromised Individuals | |
3/27/2022 | Post-Pandemic Strategies for Labs Include OIG Audit Prep and Repurposed Instruments | |
3/25/2022 | Free COVID-19 tests ending for uninsured Americans | |
3/23/2022 | AHA urges Congress to provide additional COVID-19 relief | |
3/22/2022 | COVID budget impasse halts aid to test and treat uninsured | |
3/22/2022 | Lab Advisory: Upcoming Schedule Changes for Clinical Laboratory COVID-19 Response Calls | |
3/22/2022 | HHS Distributing an Additional $413 Million in Provider Relief Fund Payments to Health Care Providers Impacted by the COVID-19 Pandemic | |
3/21/2022 | Coronavirus (COVID-19) Update: FDA to Hold Advisory Committee Meeting on COVID-19 Vaccines to Discuss Future Boosters | |
3/21/2022 | Lab Alert: FDA Recalls Specific Lot Numbers of Celltrion DiaTrust™ COVID-19 Ag Rapid Test | |
3/18/2022 | FDA Roundup: Additional COVID-19 Test FAQs. | |
3/17/2022 | Provider Relief Fund Reporting Period 2 | |
3/15/2022 | COVID-19 Claims Reimbursement - Uninsured Program Funds | |
3/11/2022 | FDA Roundup 3/11/22 | |
3/10/2022 | Lab Advisory 3/10/22. HHS Updates COVID-19 Laboratory Reporting Guidance. | |
3/10/2022 | AHA Asks CMS to Waive Medicare Advantage Prior Authorization During PHE | |
3/9/2022 | Congress set to add 151 days of telehealth coverage | |
3/8/2022 | Fact Sheet: Biden Administration Launches Nationwide Test-to-Treat Initiative Ensuring Rapid ‘On the Spot’ Access to Lifesaving COVID Treatments | |
3/8/2022 | Americans can now order four more free at-home Covid-19 tests | |
3/4/2022 | Biden extends FEMA COVID-19 funding through July 1 | |
3/2/2022 | Lab Alert: FDA Says Do Not Use These Unauthorized COVID-19 Tests | |
3/2/2022 | New ICD-10-CM/PCS Codes, Effective April 1, 2022 | |
3/1/2022 | FDA Roundup: COVID Testing Updates | |
2/25/2022 | FDA Roundup: COVID Testing Updates | |
2/24/2022 | HHS Distributing $560 Million in Provider Relief Fund Payments to Health Care Providers Affected by the COVID-19 Pandemic | |
2/21/2022 | COVID-19 CPT coding and guidance | |
2/18/2022 | FDA Roundup: COVID Vaccines & Testing Updates | |
2/16/2022 | COVID-19 Frequently Asked Questions (FAQs) on | |
2/11/2022 | Coronavirus (COVID-19) Update: FDA Authorizes New Monoclonal Antibody for Treatment of COVID-19 that Retains Activity Against Omicron Variant | |
2/8/2022 | On Feb. 4, the FDA warned people not to use the E25Bio COVID-19 Direct Antigen Rapid Test (DART) | |
2/8/2022 | Home Health Agency Providers May Be Reimbursed for COVID-19 Vaccine Administration | |
2/3/2022 | Biden-Harris Administration Will Cover Free Over-the-Counter COVID-19 Tests Through Medicare | |
2/1/2022 | AMA announces CPT update for pediatric COVID-19 vaccine candidate | |
1/28/2022 | Lab Update: CDC Updates LOINC In Vitro Diagnostic (LIVD) Test Code Mapping Tool for SARS-CoV-2 Tests | |
1/25/2022 | HHS Distributing $2 Billion More in Provider Relief Fund Payments to Health Care Providers Impacted by the COVID-19 Pandemic | |
1/24/2022 | Coronavirus (COVID-19) Update: FDA Limits Use of Certain Monoclonal Antibodies to Treat COVID-19 Due to the Omicron Variant | |
1/21/2022 | New ICD-10 Code for Post-COVID Conditions, following the 2019 Novel Coronavirus (COVID_19). | |
1/20/2022 | Healthcare Common Procedure Coding System (HCPCS) Codes Subject to and Excluded from Clinical Laboratory Improvement Amendments (CLIA) Edits. | |
1/19/2022 | COVID-19 Vaccination Requirements for Health Care Providers and Suppliers - Requirement Infographic | |
1/14/2022 | Renewal of Determination That A Public Health Emergency Exists. | |
1/13/2022 | Lab Alert: Stop Using LuSys Laboratories COVID-19 Tests | |
1/10/2022 | Biden-Harris Administration Requires Insurance Companies and Group Health Plans to Cover the Cost of At-Home COVID-19 Tests, Increasing Access to Free Tests | |
1/6/2022 | COVID-19 Vaccine & Monoclonal Antibody Products: Changes for MA Plan Claims Started January 1 | |
1/4/2022 | CDC Warns of Supply Shortages as Testing Spikes in Wake of Omicron Variant | |
1/3/2022 | Coronavirus (COVID-19) Update: FDA Takes Multiple Actions to Expand Use of Pfizer-BioNTech COVID-19 Vaccine | |
12/29/2021 | Two New Over-the-Counter At-Home COVID-19 Tests Brought to U.S. Market Quickly by Biden-Harris | |
12/23/2021 | Coronavirus (COVID-19) Update: December 23, 2021 | |
12/23/2021 | HHS Announces Availability of Nearly $48 Million to Increase the Public Health Workforce in Rural and Tribal Communities | |
12/22/2021 | New Guidance to Boost Accessibility and Equity in COVID-19 Vaccine Programs | |
12/21/2021 | Coronavirus (COVID-19) Update: December 21, 2021 | |
12/17/2021 | Coronavirus (COVID-19) Update: December 17, 2021 | |
12/14/2021 | HHS Is Releasing $9 Billion in Provider Relief Fund Payments to Support Health Care Providers Affected by the COVID-19 Pandemic | |
12/10/2021 | The FDA updated the SARS-CoV-2 Viral Mutations: Impact on COVID-19 Tests web page to share the latest information | |
12/9/2021 | MLN Connects: Publications - Independent Diagnostic Testing Facility (IDTF)- Revised. | |
12/8/2021 | HHS Awards $82 Million in American Rescue Plan Funding to Expand Home Visiting Assistance for Families Affected by the COVID-19 Pandemic | |
12/7/2021 | COVID-19 Update: Announcing the follwing actions in ongoing response effort to the pandemic. | |
12/3/2021 | FDA Expands Authorization of Two Monoclonal Antibodies for Treatment and Post-Exposure Prevention of COVID-19 to Younger Pediatric Patients, Including Newborns | |
12/3/2021 | Lab Alert: CDC Update on the SARS-CoV-2 Omicron Variant | |
12/1/2021 | COVID-19 FAQs on | |
11/30/2021 | COVID-19 Update: The FDA is actively working to quickly address any potential impacts of the new omicron variant on the tools to fight the pandemic. | |
11/24/2021 | COVID-19: Pfizer & Modena Booster Shots for 18 Years and Older | |
11/23/2021 | COVID Update: Over-the-counter (OTC) COVID-19 antigen diagnostic tests | FDA |
11/22/2021 | Over The Counter (OTC) Home Testing and CLIA Applicability | |
11/18/2021 | Changes to Nursing Home Visitation COVID-19 (Revised) & COVID-19 Survey Activities | |
11/16/2021 | The FDA took several important actions intended to support ongoing nationwide COVID-19 testing efforts. | |
11/15/2021 | FDA Updates Test Policies to Help to Ensure Accuracy and Reliability of Tests and Increase Access to At-Home Tests | |
11/10/2021 | HHS Announces $143.5 Million to Expand Community-Based Efforts to Address Barriers to COVID-19 Vaccination | |
11/4/2021 | COVID-19 Vaccines for Children | |
11/4/2021 | Biden-Harris Administration Issues Emergency Regulation Requiring COVID-19 Vaccination for Health Care Workers | |
11/4/2021 | COVID-19 Vaccine Webinar for Rural Communities | |
10/27/2021 | HRSA COVID-19 Claims Reimbursement to Health Care Providers/ acilities for Testing and Treatment of the Uninsured | |
10/26/2021 | The FDA Issued an EUA for the Celltrion DiaTrust COVID-19 Ag Home Test, an OTC COVID-19 diagnostic antigen test. | |
10/21/2021 | Lab Alert: CDC Updates LOINC In Vitro Diagnostic (LIVD) Test Code Mapping Tool for SARS-CoV-2 Tests to Include SNOMED-CT Saliva Terms | |
10/21/2021 | CDC Expands Eligibility for COVID-19 Booster Shots | |
10/15/2021 | HHS renews COVID-19 emergency declaration for 90 days | |
10/5/2021 | COVID-19 Update | |
10/4/2021 | FDA Authorizes Additional OTC Home Test to Increase Access to Rapid Testing for Consumers | |
10/4/2021 | Lab Alert: Ellume Issues Voluntary Recall of Specific Lots of Ellume COVID-19 Home Tests | |
9/29/2021 | New COVID-19 Vaccine Codes: September Update | |
9/24/2021 | CMS Will Pay for COVID-19 Booster Shots, Eligible Consumers Can Receive at No Cost | |
9/22/2021 | Lab Advisory: CDC Updates SARS-CoV-2 Variant Classifications | |
9/22/2021 | FDA Authorizes Booster Dose of Pfizer-BioNTech COVID-19 Vaccine for Certain Populations | |
9/10/2021 | COVID-19 Update | |
9/10/2021 | HHS Announces the Availability of $25.5 Billion in COVID-19 Provider Funding | |
9/3/2021 | AMA Announces Update to COVID-19 Vaccine CPT Codes | |
9/2/2021 | Lab Advisory: Shortage of COVID-19 Rapid Tests May Increase Demand for Laboratory Testing | |
9/2/2021 | Provider Enrollment Activities Resume in October | |
9/1/2021 | FDA to Hold Advisory Committee Meeting to Discuss Pfizer-BioNTech’s Application for COVID-19 Booster | |
8/24/2021 | CMS Expands Medicare Payments for At-Home COVID-19 Vaccinations | |
8/23/2021 | FDA Approves First COVID-19 Vaccine | |
8/18/2021 | Joint Statement from HHS Public Health and Medical Experts on COVID-19 Booster Shots | |
8/9/2021 | UPDATE: Lab Advisory 8/9/21: SARS-CoV-2 Variant Classification Updates | |
8/6/2021 | Clinical Laboratory COVID-19 Response Call on Monday, August 23 at 3:00 PM ET | |
8/2/2021 | Lab Alert: Clarifications about the Retirement of the CDC 2019 Novel Coronavirus (2019-nCov) Real-Time RT-PCR Diagnostic Panel | |
8/2/2021 | Hospital Inpatient Prospective Payment System Final Rule Increases Payments to Treat COVID-19 and Improves Quality of Data Collection | |
7/30/2021 | Coronavirus (COVID-19) Update | |
7/21/2021 | Lab Alert: Changes to CDC RT-PCR for SARS-CoV-2 Testing | |
7/20/2021 | Lab Advisory: SARS-CoV-2 Variant Classification Updates | |
7/18/2021 | Lab Alert: FDA Revokes EUA for Curative SARS-CoV-2 Assay | |
7/15/2021 | Lab Advisory: CDC Updates Pooling Guidance and Overview of Testing for SARS-CoV-2 Web Pages | |
7/13/2021 | Revised fact sheets for the Johnson & Johnson (Janssen) COVID-19 Vaccine to include information pertaining to an observed increased risk of Guillain-Barré Syndrome (GBS) following vaccination. | |
7/8/2021 | COVID-19 Snapshot: Impact on the Medicare Population | |
7/8/2021 | COVID-19 Accelerated and Advance Payments: Updated FAQs. | |
7/6/2021 | Lab Advisory: SARS-CoV-2 Variants AY.1 and AY.2 Now Aggregated with Delta Variant B.1.617.2 | |
6/30/2021 | CDC Launches New COVID-19 Viral Testing Tool | |
6/29/2021 | Lab Update: SARS-CoV-2 Variant Classification Changes | |
6/17/2021 | CMS Infographic: Medicare Payment for COVID-19 Vaccination Administered in the Home | |
6/16/2021 | CDC Updates Guidance for Reporting SARS-CoV-2 Sequencing Results. | |
6/15/2021 | Coronavirus (COVID-19) Update | |
6/14/2021 | Lab Alert: Sodium Citrate Blood Specimen Collection Tubes in Short Supply | |
6/14/2021 | Lab Advisory: CDC Launches New COVID-19 Viral Testing Tool | |
6/10/2021 | CMS increase provider payment for in-home COVID-19 vaccinations | |
6/9/2021 | Biden Administration Continues Efforts to Increase Vaccinations by Bolstering Payments for At-Home COVID-19 Vaccinations for Medicare Beneficiaries | |
6/9/2021 | HHS Secretary Xavier Becerra to Insurers & Providers: COVID-19 Vaccines and Testing Must be Free for Patients | |
5/28/2021 | Lab Advisory: CDC Updates Testing Strategies for SARS-CoV-2 Web Page | |
5/25/2021 | Coronavirus (COVID-19) Update: May 25, 2021 | |
5/25/2021 | HHS to Dedicate $4.8 Billion from American Rescue Plan to COVID-19 Testing for the Uninsured | |
5/21/2021 | Coronavirus (COVID-19) Update: May 21, 2021 | |
5/20/2021 | Lab Advisory: CDC Updates NAATs and Self-Testing Web Pages | |
5/19/2021 | Antibody Testing Is Not Currently Recommended to Assess Immunity After COVID-19 Vaccination: FDA Safety Communication | |
5/18/2021 | CDC Updates Interim Guidance for Antigen Testing for SARS-CoV-2 | |
5/5/2021 | SARS-CoV-2 Variant Classifications and Definitions | |
5/3/2021 | HHS Launches New Reimbursement Program for COVID-19 Vaccine Administration Fees not Covered by Insurance | |
4/26/2021 | Time to Say Goodbye to Some Insurers’ Waivers for Covid Treatment Fees | |
4/21/2021 | FDA Continues Important Steps to Ensure Quality, Safety and Effectiveness of Authorized COVID-19 Vaccines | |
4/20/2021 | The FDA issued a pooling and serial testing amendment for many molecular diagnostic COVID-19 tests that had received an emergency use authorization (EUA) for testing individual samples. | |
4/16/2021 | Medicare FFS Claims: | |
4/15/2021 | Message from HHS-OIG Leadership on the COVID-19 Vaccination Program and Provider Compliance | |
4/6/2021 | The FDA issued an Emergency Use Authorization (EUA) to Symbiotica, Inc., for the COVID-19 Self-Collected Antibody Test System | |
4/2/2021 | HHS Secretary Xavier Becerra Announces Expansion of COVID-19 Vaccine Program to All Community Health Centers Across the Country | |
4/2/2021 | New web page posted: SARS-CoV-2 Viral Mutations: Impact on COVID-19 Tests for clinical laboratory staff and health care providers about the impact of viral mutations on COVID-19 molecular, antigen, and serology tests | |
4/1/2021 | Repayment of COVID-19 Accelerated and Advance Payments Began on March 30, 2021 | |
3/30/2021 | Updated Serology EUA COVID-19 Templates Available | |
3/30/2021 | New FDA web page - SARS-CoV-2 Viral Mutations: Impact on COVID-19 Tests - for clinical laboratory staff and health care providers about the impact of viral mutations on COVID-19 molecular tests | |
3/26/2021 | FDA issues emergency use authorization (EUA) to the Twist Bioscience Corporation for their SARS-CoV-2 NGS Assay | |
3/26/2021 | Lab Advisory: CDC Publishes New Web Page on Nucleic Acid Amplification Tests (NAATs) | |
3/22/2021 | Lab Update: CMS Posts FAQ for Reporting Sequencing Results for SARS-CoV-2 Variants | |
3/15/2021 | Medicare Payment Increase for COVID-19 Vaccine | |
3/13/2021 | Lab Alert: FDA Issues Letter about Potential False Results with Roche cobas SARS-CoV-2 & Influenza Test | |
3/9/2021 | Senate Passes $1.9 Trillion COVID-19 Bill; Several CAP-Backed Provisions Move Forward | |
3/9/2021 | FDA issued an Emergency Use Authorization (EUA) to Cue Health Inc. for its over-the-counter at-home diagnostic test for COVID-19. | |
3/9/2021 | Medicare Part B Payment for COVID-19 Vaccines and Certain Monoclonal Antibodies during the Public Health Emergency | |
3/5/2021 | COVID-19 Update: FDA Issues Authorization for First Molecular Non-Prescription, At-Home Test | |
3/4/2021 | COVID-19 Vaccine Administration: Insurance Coverage, MBI, & MSP | |
3/2/2021 | Lab Advisory: FDA Issues New Guidance for Evaluating Impact of Viral Mutations on COVID-19 Tests | |
3/2/2021 | COVID-19 Update: The agency issued an Emergency Use Authorization (EUA) to Quidel for its QuickVue At-Home COVID-19 Test for at-home use with a prescription | |
2/27/2021 | House Approves Large COVID-19 Relief Bill; Includes $7.5 Billion for Vaccine Distribution | |
2/26/2021 | Biden Administration Strengthens Requirements that Plans and Issuers Cover COVID-19 Diagnostic Testing Without Cost Sharing and Ensures Providers are Reimbursed for Administering COVID-19 Vaccines to Uninsured | |
2/26/2021 | ACLA Statement on President Biden’s Actions to Close Coverage Gaps for COVID-19 Testing | |
2/12/2021 | COVID-19 Update: The FDA revised its guidance, Investigational COVID-19 Convalescent Plasma and associated web page, to reflect the reissued Emergency Use Authorization for COVID-19 convalescent plasma | |
2/11/2021 | COVID-19: Revised Clinician Codes Accepted with CS Modifier | |
2/3/2021 | COVID-19 Claims Reimbursement Program Update for the Uninsured | |
2/2/2021 | Lab Advisory: CDC Publishes New Web Pages on Genomic Surveillance for SARS-CoV-2 Variants | |
1/29/2021 | COVID-19 Update: The FDA has added content to the Q&A appendix in “Conduct of Clinical Trials of Medical Products During the COVID-19 Public Health Emergency" | |
1/28/2021 | HHS Announces Marketplace Special Enrollment Period for COVID-19 Public Health Emergency | |
1/21/2021 | ACLA Statement on President Biden's Actions to Combat COVID-19 | |
1/19/2021 | Find your COVID-19 Vaccine CPT® Codes | |
1/8/2021 | FDA Issues Alert Regarding SARS-CoV-2 Viral Mutation to Health Care Providers and Clinical Laboratory Staff | |
1/8/2021 | Coronavirus (COVID-19) Update: January 8, 2021 | |
1/4/2021 | New ICD-10-CM code for the | |
12/22/2020 | Coronavirus (COVID-19) Update: December 22, 2020 | |
12/19/2020 | CMS Updates FAQs for CLIA Guidance during the COVID-19 Public Health Emergency | |
12/15/2020 | FDA Takes Key Action in Fight Against COVID-19 By Issuing Emergency Use Authorization for First COVID-19 Vaccine | |
12/15/2020 | FDA Authorizes Antigen Test as First Over-the-Counter Fully At-Home Diagnostic Test for COVID-19 | |
12/11/2020 | COVID-19 and in vitro diagnostics: New market forces at play | |
12/10/2020 | CMS offers guidance in billing Medicare for COVID-19 antibody treatment | |
12/10/2020 | FAQs–Application of OIG's Administrative Enforcement Authorities to Arrangements Directly Connected to the Coronavirus Disease 2019 (COVID-19) Public Health Emergency | |
12/7/2020 | Lab Advisory: CMS Revises Enforcement Discretion for SARS-CoV-2 Point-of-Care Tests | |
12/5/2020 | Lab Update: CDC Updates SARS-CoV-2 Antigen Testing Guidance | |
12/3/2020 | Lab Update: CDC Offers New COVID-19 Specimen Collection Infographics | |
12/4/2020 | 13 insurers extending COVID-19 cost-sharing waivers into 2021 | |
12/3/2020 | COVID-19 Frequently Asked Questions (FAQs) on Medicare Fee-for-Service (FFS) Billing | |
12/1/2020 | Job Aids for Laboratory Professionals | |
12/1/2020 | Clinical Laboratory COVID-19 Response Calls | |
11/24/2020 | Guidance for SARS-CoV-2 Point-of-Care Testing | |
11/24/2020 | Pathologists Advocate for Higher COVID-19 Payments During AMA Meeting | |
11/24/2020 | A Closer Look at COVID-19 Diagnostic Testing | |
11/23/2020 | 2020 Clinical Lab & Pathology Resources | |
11/19/2020 | HHS Launches Pilot Program of Fast Molecular POC Test for COVID-19 | |
11/18/2020 | Virtual Town Hall Series - Coronavirus (COVID-19) Test Development and Validation | |
11/18/2020 | The FDA issued an EUA for the first COVID-19 diagnostic test for self-testing at home that provides rapid results | |
11/18/2020 | The FDA published a new "FDA Insight" podcast titled: "Personal Protective Equipment and COVID-19" | |
11/17/2020 | CAP Members Call on Congress to Stop Medicare Cuts | |
11/17/2020 | CAP Asks CMS to Reduce COVID-19 Laboratory Reporting Burdens, Increase Testing Resources | |
11/11/2020 | CMS Details Medicare Payment for New COVID-19 Antibody Drug | |
11/10/2020 | AMA Announces Vaccine-Specific CPT Codes for COVID-19 Immunizations | |
11/9/2020 | The FDA issued an emergency use authorization (EUA) for the investigational monoclonal antibody therapy bamlanivimab for the treatment of mild-to-moderate COVID-19 in adult and pediatric patients | |
11/2/2020 | Clinical Laboratories Need Creative Staffing Strategies to Keep and Attract Hard-to-Find Medical Technologists, as Demand for COVID-19 Testing Increases |